Canadian Journal of Physiology and Pharmacology
@PhysiolPharma
Followers
74
Following
22
Statuses
75
A @cdnsciencepub journal reporting current research in all aspects of physiology, nutrition, pharmacology, and toxicology.
Joined July 2024
📣 Call for papers in CJPP! Incretins in Action: Unlocking New Frontiers from Bench to Bedside We're highlighting effectiveness, efficacy, safety, & health economics of incretin ▶️ Guest eds: Nicholas Carris & Kevin Cowart
0
0
0
It's #WomensHeartWeek! Heart disease is the top cause of death for women globally. However, women are less likely to be referred to cardiac rehabilitation and 50% less likely to participate. Spread the word and raise awareness! ❤️
0
0
0
It's #WomensHeartWeek! What are common heart attack symptoms in women? • Dizziness, shortness of breath • Chest pain or discomfort • Indigestion, nausea, or vomiting Share to raise awareness! ❤️
0
0
0
It's #WomensHeartWeek ❤️ Fact: Most guidelines for diagnosis of heart disease are mostly based on studies of males Learn about gender disparity in heart research & advances in the field in the Intro to our #WomensHeartHealth special issue 🔗 @WomenHeartOrg
0
0
0
It's #WomensHeartWeek! A whopping 50% of women experience their first symptoms after 65 years of age! Heart disease is not just a man's issue. Spread the word! ❤️
0
0
0
It's #WomensHeartWeek Did you know that heart disease is on the rise in women? 💔It is underdiagnosed 💔It is understudied 💔There is a lack of awareness Please help spread the word. @CWHHC @WomenHeartOrg @RabinovichInna @cdnsciencepub
0
2
2
It's #WomensHeartHealth awareness week! Heart disease is often considered to be primarily a "man's disease", yet heart disease is the number one cause of death in women worldwide. 💔 @CWHHC @WomenHeartOrg @RabinovichInna @cdnsciencepub
0
0
0
Next week marks #WomensHeartWeek: Feb 1-7 ❤️🧑🏽👱🏻♀️ To help promote awareness, this week we will be posting facts about Women's Heart Health You can also check out our 3-part special issue on Women's #HeartHealth: Pt 1 🔗 @CWHHC @RabinovichInna
#OpenAccess
0
0
0
Our most-read article reflects the intellectual curiosity of 2024, resonating with @cdnsciencepub readers across the globe! Explore our top research in our Year in Review 💡▶️ #BestofCSP
0
0
0
The January 2025 issue of CJPP is now available online! 🩺💊❤️ Topics covered in this month's issue include #AirwaySmoothMuscle, #T2DM, #PulmonaryVasoconstriction, and #BreastCancer 📖
0
0
0
📣CJPP's January #EditorsChoice is by Ynuk Bossé: The airway smooth muscle and the pipe dream of better bronchodilators 📖 🔗 @IUCPQ @CIHR_IRSC @PharmacologyCan
#OpenAccess #drugs #LungFunction #RespiratoryDiseases
0
0
0
✨ 2️⃣0️⃣2️⃣5️⃣ ✨ As we welcome the new year, we’re sending our best wishes for hope, joy, and good health from everyone at @PhysiolPharma! Thank you to our incredible authors, reviewers, and researchers for making 2024 an outstanding year in science!
0
0
1
In 2024, together with our publisher @cdnsciencepub we connected editors, authors, reviewers, and readers worldwide. Read our Year in Review with top articles and highlights from a year of advancing global research 💡▶️ #BestofCSP
0
0
0
Nebivolol prevents redox imbalance and attenuates bladder dysfunction induced by cyclophosphamide in mice | Jesus et al This article is now available in Dec CJPP 💊🩺: 🔗 @usponline
#nebivolol #OxidativeStress #cystometry
0
0
0
Now in Dec CJPP 🩺💊: Cardiovascular adverse events associated with norepinephrine–dopamine reuptake inhibitors: a pharmacovigilance study of the FDA Adverse Event Reporting System | Kandukuru et al 🔗 @USouthFlorida
#OpenAccess #FAERS #FDA #cardiovascular
0
0
0
Now in the December issue of CJPP🩺💊 Sarcopenia: recent advances for detection, progression, and metabolic alterations along with therapeutic targets | Ali et al 🔗 @wanling_xuan @USouthFlorida
#OpenAccess #sarcopenia #aging #exercise
0
1
0